Silence Therapeutics plc Goodwill, Foreign Currency Translation Gain (Loss)
Silence Therapeutics plc (SLNCF) reported Goodwill, Foreign Currency Translation Gain (Loss) of -$296.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Income Statement › Other Income
us-gaap:GoodwillForeignCurrencyTranslationGainLoss · last filed 2026-08-10
- Silence Therapeutics plc goodwill, foreign currency translation gain (loss) for the quarter ending 2026-06-30 was -$33.00K.
- Silence Therapeutics plc goodwill, foreign currency translation gain (loss) for the quarter ending 2026-03-31 was -$263.00K, a 121.40% decline year-over-year.
- Silence Therapeutics plc goodwill, foreign currency translation gain (loss) for the quarter ending 2025-12-31 was $9.00K.
- Silence Therapeutics plc goodwill, foreign currency translation gain (loss) for the quarter ending 2025-09-30 was -$9.00K.
- Silence Therapeutics plc goodwill, foreign currency translation gain (loss) for fiscal 2025 was $1.23M.
- Silence Therapeutics plc goodwill, foreign currency translation gain (loss) for fiscal 2024 was -$589.00K, a 297.65% decline from fiscal 2023.
- Silence Therapeutics plc goodwill, foreign currency translation gain (loss) for fiscal 2023 was $298.00K.
| Period end | Goodwill, Foreign Currency Translation Gain (Loss) 3 month | Goodwill, Foreign Currency Translation Gain (Loss) 3 month as first filed | Goodwill, Foreign Currency Translation Gain (Loss) 6 month | Goodwill, Foreign Currency Translation Gain (Loss) 6 month as first filed | Goodwill, Foreign Currency Translation Gain (Loss) 9 month | Goodwill, Foreign Currency Translation Gain (Loss) 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | -$33.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | -$296.00K 10-Q · filed 2026-08-10 | -$287.00K derived: sum of 3 quarters · filed 2026-08-10 | -$296.00K derived: sum of 4 quarters · filed 2026-08-10 | ||
| 2026-03-31 | -$263.00K 10-Q · filed 2026-05-07 | -$254.00K derived: sum of 2 quarters · filed 2026-05-07 | -$263.00K derived: sum of 3 quarters · filed 2026-05-07 | -$263.00K derived: sum of 4 quarters · filed 2026-08-10 | ||
| 2025-12-31 | $9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $0.00 derived: sum of 2 quarters · filed 2026-03-05 | $0.00 derived: sum of 3 quarters · filed 2026-08-10 | $1.23M 10-K · filed 2026-03-05 | ||
| 2025-09-30 | -$9.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$9.00K derived: sum of 2 quarters · filed 2026-08-10 | $1.22M 10-Q · filed 2025-11-06 | $1.22M derived: sum of 4 quarters · filed 2026-08-10 | ||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $1.23M 10-Q · filed 2026-08-10 | $1.23M 10-Q · filed 2025-08-07 | $1.23M derived: sum of 3 quarters · filed 2026-08-10 | $1.23M derived: sum of 4 quarters · filed 2026-08-10 | |
| 2025-03-31 | $1.23M 10-Q · filed 2026-05-07 | $392.00K 10-Q · filed 2025-05-08 | $1.23M derived: sum of 2 quarters · filed 2026-05-07 | $1.23M derived: sum of 3 quarters · filed 2026-05-07 | $272.00K derived: sum of 4 quarters · filed 2026-05-07 | |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-05 | $0.00 derived: sum of 2 quarters · filed 2026-03-05 | -$957.00K derived: sum of 3 quarters · filed 2026-03-05 | -$589.00K 10-K · filed 2026-03-05 | ||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | -$957.00K derived: sum of 2 quarters · filed 2025-11-06 | -$589.00K 10-Q · filed 2025-11-06 | |||
| 2024-06-30 | -$957.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | -$589.00K 10-Q · filed 2025-08-07 | ||||
| 2024-03-31 | $368.00K 10-Q · filed 2025-05-08 | |||||
| 2023-12-31 | $298.00K 10-K · filed 2025-02-27 |